Pharmacokinetics of protein C and antithrombin in the fetal lamb: a model to predict human neonatal replacement dosing.

about

Pharmacokinetics of protein C and antithrombin in the fetal lamb: a model to predict human neonatal replacement dosing.

Item

http://www.wikidata.org/entity/Q36982485

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Pharmacokinetics of protein C ...... n neonatal replacement dosing.

@en

type

Item

label

Pharmacokinetics of protein C ...... n neonatal replacement dosing.

@en

prefLabel

Pharmacokinetics of protein C ...... n neonatal replacement dosing.

@en

P1476

Pharmacokinetics of protein C ...... an neonatal replacement dosing

@en

P2093

Linda J Jacobson

http://www.w3.org/2001/XMLSchema#string

Marilyn J Manco-Johnson

http://www.w3.org/2001/XMLSchema#string

William W Hay

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate

Homozygous protein C deficiency: early treatment with warfarin

Diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis

Severe neonatal protein C deficiency: prevalence and thrombotic risk

Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency

Complete antithrombin deficiency in mice results in embryonic lethality.

The two-compartment open-system kinetic model: a review of its clinical implications and applications.

Thrombosis during infancy and childhood: what we know and what we do not know.

Development of the hemostatic system in the neonate and young infant.

Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement treatment.

P304

279-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000178025

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michele Hacker

P577

2008-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19039246

http://www.w3.org/2001/XMLSchema#string

P932

3701438

http://www.w3.org/2001/XMLSchema#string